Zymeworks Inc.

NASDAQ:ZYME

Biotechnology

Healthcare
$26.86 -1.64%

-$0.38 today

Market cap
$1.87B
Beta
1.14
P/E (TTM)
-16.6
EPS (TTM)
-$1.37
52W Low $11.51High $29.75

Volume 0.99M

Average 0.71M

Balance Sheet

Inspect the capital base behind the business.

Assets

$346.53M

FY 2025 · Annual

-25.2% YoY

Liabilities

$78.03M

FY 2025 · Annual

-37.2% YoY

Equity

$268.50M

FY 2025 · Annual

-20.7% YoY

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents201.87M400.91M157.56M66.1M41.16M
Short-term Investments50.74M91.32M216.77M159.67M187.64M
Net Receivables15.61M33.4M19.48M55.82M4.64M
Inventory00000
Other Current Assets019.07M19.12M18.86M0
Total Current Assets288.22M544.71M412.93M300.45M233.44M
Property, Plant & Equipment (Net)49.77M47.65M37.54M34.32M0
Goodwill12.02M12.02M12.02M12.02M12.02B
Intangible Assets21.47M26.38M25.28M4.58M1.35B
Long-term Investments886K886K81.93M98.43M41.79M
Tax Assets3.07M1.35M3.62M4.39M0
Other Non-current Assets13.7M15.74M7.57M8.92M(13.29B)
Total Non-current Assets100.91M104.02M167.95M162.64M113.09M
Total Assets389.13M648.73M580.88M463.09M346.53M
Account Payables5.17M7.86M6.21M3.9M4.4M
Short-term Debt00000
Tax Payables017.08M1.81M1.38M0
Deferred Revenue02.35M3.7M25.59M2.42M
Other Current Liabilities11.1M16.01M8.68M7.49M9.67M
Total Current Liabilities71.85M95.63M55.76M88.29M42.32M
Long-term Debt00000
Deferred Tax Liabilities1.57M1.79M3.3M4.76M6.03M
Deferred Revenue (Non-current)32.94M30.59M32.94M14.61M14.61M
Other Non-current Liabilities2.65M2.98M1.61M895K278K
Total Non-current Liabilities68.19M60.14M60.31M36.03M35.71M
Total Liabilities140.04M155.77M116.07M124.32M78.03M
Common Stock741.15M906.76M1.01B1.02B1.11B
Retained Earnings(683.1M)(558.76M)(677.44M)(830.34M)(953.16M)
Accumulated OCI(6.66M)(6.66M)(6.6M)(6.95M)(6.08M)
Other Stockholders Equity00000
Minority Interest00000
Total Equity249.09M492.96M464.81M338.77M268.5M
Total Debt32.33M28.11M26.72M18.51M18.27M
Net Debt(169.53M)(372.8M)(130.84M)(47.6M)(22.89M)

Balance Sheet

Assets, liabilities & equity

Cash & Equivalents$100.5M
Receivables$413.9M
Other Current$18.1M
Total Current Assets$532.4M
PP&E (Net)$63.5M
Goodwill$116.4M
Intangible Assets$431.0M
Tax Assets$5.8M
Other Non-current$27.2M
Total Non-current Assets$644.0M
Total Assets$1.2B

Analysis

Selected assets total $1.2B for Latest. The largest visible component is Intangible Assets at $431.0M, about 36.6% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 9, 2026
8-K/A8-K/A filingNov 9, 2026
10-QQuarterly reportNov 9, 2026
ARSARS filingOct 26, 2026
DEFA14ADEFA14A filingOct 26, 2026

How much cash does ZYME have?

Zymeworks Inc. (ZYME) reported $41.16M in cash and equivalents in fiscal 2025.

How much debt does ZYME carry?

Zymeworks Inc. (ZYME) reported $18.27M of total debt, with net debt of -$22.89M.